Genetically altered T cells aid kidney treatment
Researchers have found that genetically modified T cell therapy, originally developed to treat blood cancers, can now be used to facilitate kidney transplants for patients with severe allergies that prevent them from receiving compatible organs. This is achieved by modifying their immune cells to reduce the production of harmful antibodies and re-injecting them into their bodies. This approach led to a significant decrease in harmful antibodies and successful kidney transplants in three patients in the United States and Germany, marking an important advance in the field of organ transplantation.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)